Co-founders of Veripad, a startup launched at the Zahn Innovation Center by three City College of New York graduates, relocated to Nairobi, Kenya as part of the prestigious Merck KGaA Accelerator Program. The three-month program in Africa offers extensive funding, mentorship and technical support for budding entrepreneurs in healthcare. “Winning the Zahn Social Impact Prize gave us a sense of validation that our product was viable and that our dream of reducing mortalities from counterfeit medication was within reach,” said Y-Lan Nguyen, co-founder and CAO of Veripad. Bishoy Ghobryal (CEO) and
Read more